Why is the IPH (ASX:IPH) share price charging 8% higher?

The IPH share price is charging higher today, up 8% in late morning trade. We take a look at the company's latest results.

| More on:

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

The IPH Ltd (ASX: IPH) share price is charging higher today, up 8% in late morning trade.

The share price gains come following the release of the intellectual property services provider's results for the financial year ending 31 December (H1 FY21).

A young man pointing up looking amazed, indicating a surging share price movement for an ASX company

Image source: Getty Images

Financial results for H1 FY21

In this morning's ASX release, IPH reported it had managed a strong half-year, despite headwinds from a stronger Aussie dollar and the market disruptions caused by COVID-19.

The company reported statutory net profit after tax (NPAT) of $26.8 million. That was down 1.5% from the $27.2 million reported in the prior corresponding period(PCP). Diluted earnings per share (EPS) also slipped to 12.4 cents from 12.9 cents in H1 FY20. IPH said an increase in non-cash amortisation of intangible assets had impacted the statutory results. This was directly related to its Xenith IP acquisition

Underlying NPAT increased 3% to $37.6 million while underlying earnings before income, tax, depreciation, and amortisation (EBITDA) grew 2% to $61.7 million.

Operating cash flow increased by 39% year-on-year.

The company also bumped its interim dividend up by 4% from the prior corresponding half year. Resulting in 14 cents per share (cps), 50% franked.

Commenting on the results IPH CEO, Andrew Blattman said:

Our Asian IP business continues to perform well. While revenue was down slightly on the prior period, we continued to generate margin accretive earnings from leveraging our extensive network across the region, including a 39% increase in client patent and trade mark referrals from acquired companies (AJ Park and former Xenith businesses)…

Our business in China and Hong Kong SAR performed well in the half with excellent filing growth of 18% and 23% respectively. In Singapore, IPH Group maintained its number one patent market share of 23.2% for the calendar year ended 31 December 2020.

IPH also remains the market leader in Australia. It reported a combined group patent market share of 36.8% for the half-year. This is said to include Baldwins on a proforma basis and excludes innovation patents.

Share price snapshot

The IPH share price has yet to recover from the hit it took in 2020. This was due to the wider COVID-driven market selloff that occurred last year. Over the past 12 months, shares are down 33%. That compares to a 3% loss on the All Ordinaries Index (ASX: XAO).

With today's intraday gains factored in, the IPH share price is up 1% so far in 2021.

Bernd Struben has no position in any of the stocks mentioned. The Motley Fool Australia's parent company Motley Fool Holdings Inc. recommends IPH Ltd. The Motley Fool Australia has recommended IPH Ltd. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Bruce Jackson.

More on Share Market News

The silhouettes of ten people holding hands with their arms raised against the sky, as the sun rises or sets in the background.
Share Gainers

Here are the top 10 ASX 200 shares today

It was a happy hump day session for the ASX.

Read more »

A male sharemarket analyst sits at his desk looking intently at his laptop with two other monitors next to him showing stock price movements
Broker Notes

Top brokers name 3 ASX shares to buy today

Here's what brokers are recommending as buys this week.

Read more »

Scientists working in the laboratory and examining results.
Opinions

3 reasons to buy CSL shares today

The ASX biotech company has great growth potential this year.

Read more »

a man weraing a suit sits nervously at his laptop computer biting into his clenched hand with nerves, and perhaps fear.
Share Fallers

Why Brightstar, EQ Resources, Novonix, and Pro Medicus shares are falling today

These shares are under pressure on hump day. But why?

Read more »

A happy family of four on holidays stand on a jetty and cheer.
Broker Notes

Down 40% in 2026, should you buy the big dip in Life360 shares?

A leading analyst offers his outlook for Life360 shares.

Read more »

Buy and sell on yellow paper with pins on them and several share price lines.
Broker Notes

Sell alert! Why this expert is calling time on Nuix and Brainchip shares

A leading analyst forecasts more pain to come for Brainchip and Nuix shares. But why?

Read more »

Ecstatic woman looking at her phone outside with her fist pumped.
Share Gainers

Why EOS, Humm, New Hope, and Sims shares are storming higher today

These shares are having a good session on hump day. But why?

Read more »

a man lies on his back on grass with his eyes shut and a contented look on his face as though he is dreaming
Broker Notes

With global populations ageing, are ResMed shares a good buy today?

A leading expert delivers his verdict on the outlook for ResMed shares.

Read more »